Brief: Essity Says Board To Evaluate Alternatives For Consumer Tissue, Including Potential Separation
06/05/2026 19:37
May 6 (Reuters) - Essity AB (publ) ESSITYa.ST: ESSITY INITIATES STRATEGIC REVIEW OF THE CONSUMER TISSUE BUSINESS AREA ESSITY - BOARD TO EVALUATE ALTERNATIVES FOR CONSUMER TISSUE, INCLUDING POTENTIAL SEPARATION Source text: ID:nPn6Jrr4la Further company coverage: [ESSITYa.ST] ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Essity AB (publ)
See all newsEurope Research Roundup: Aixtron, Lenzing, Novo Nordisk
Brief: Finansinspektionen: Katarina Martinson Bought Around SEK 129 Million Worth Of Essity Shares
Corrected: BRIEF-Essity Board Member Buys SEK 29.6 Mln Worth Of Essity Shares
Brief: Essity Targets Adjusted EBITA Margin Above 12-19%
Brief: Essity Says Board To Evaluate Alternatives For Consumer Tissue, Including Potential Separation